Philip Morris can market Zyn as lower risk than cigarettes

Category: Markets

Published: 2026-07-02T08:59:36.000Z

The FDA has authorized Philip Morris International to market 20 variants of its Zyn nicotine pouches as less harmful than cigarettes, marking the first time this distinction has been given to a nicotine pouch. This decision allows the company to state that Zyn poses less risk for diseases like lung cancer and stroke compared to combustible alternatives. Despite this authorization, an analyst suggests the impact on Zyn's market share may be limited as many consumers already recognize non-combustibles as less harmful, and competitors are expected to receive similar distinctions.

Read the original source

News summary curated and translated by CausifyMarket. Always consult original sources before making any financial decision.